Home › Amyotrophic Lateral Sclerosis › NCT06203106
NYSCF Scientific Discovery Biobank
Who can join
30 Days · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 30 days or older. * Diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest or healthy control. * Adults with decisional capacity must provide written informed consent unless physical limitations preclude signing. * Adults without decisional capacity to consent must a have diagnosis of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease and Related Dementias (AD/ADRD); Batten Disease, Corticobasal Degeneration (CBD), Dementia, Frontotemporal Dementia (FTD), Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson's Disease (PD), Parkinsonism, and/or Progressive Supranuclear Palsy, and must provide assent; a legally authorized representative (LAR) must also provide written informed consent. * Minors undergoing skin collection for research purposes must have a condition, disease, genetic background, or trait of interest and parental/guardian consent. * Minors undergoing blood, and/or saliva collection for research purposes may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent. * Minors transferring biological samples and associated data from a procedure outside of the research may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent. Exclusion Criteria: * Wards of the state. * For prospective skin samples: history of keloid formation, coagulation disorder, or allergy to the anesthetic. * For prospective blood samples: history of coagulation disorder. * For all prospective sample collections: 1) Subjects who refuse to adhere to NYSCF's and/or a collection site's safety protocol(s) will be excluded; 2) Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter (mcL) of blood will be excluded due to increased risk of infection.
About the study
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use.
Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.
What is being tested
- Biological Sample Collection (other)
Sponsor: New York Stem Cell Foundation Research Institute · Participants: 10,000 · Started: Nov 10, 2022
Contact the study team
- Clinical Research Office · Phone: 212-927-1801
Official record on ClinicalTrials.gov — NCT06203106
Locations in the U.S.
| New York | New York Stem Cell Foundation Research Institute, New York |
Conditions
- Amyotrophic Lateral Sclerosis
- Alzheimer's Disease
- Neuronal Ceroid-Lipofuscinoses
- Corticobasal Degeneration
- Dementia
- Frontotemporal Dementia
- Huntington's Disease
- Lewy Body Dementia
- Multiple Sclerosis
- Multiple System Atrophy
- Parkinson's Disease
- Progressive Supranuclear Palsy
- Diabetes
- Type 2 Diabetes
- Type 1 Diabetes
- Macular Degeneration
- Ovarian Cancer
- Cervical Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
- Post-Traumatic Stress Disorder
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.